AMIVAS
  • Home
  • Products
    • ORDERING
      • Order Artesunate
    • MEDICAL INQUIRIES
      • Medical Affairs
      • Report Adverse Drug Reaction / Adverse Event
    • ARTESUNATE
      • Product Information
  • Severe Malaria
  • About
    • Careers
    • Partnering
  • News
  • Contact Us
Select Page
AMIVAS Launches Europe’s First & Only Licensed Severe Malaria Treatment

AMIVAS Launches Europe’s First & Only Licensed Severe Malaria Treatment

by admin | Oct 24, 2024 | Ticker

Artesunate AMIVAS® is now available for purchase across Europe and U.K. Artesunate AMIVAS®, approved by EU Commission and U.K.’s Medicine and Healthcare Product Regulatory Agency to treat severe malaria both in children and adults in Europe, is the only fully licensed...

Recent Posts

  • AMIVAS Launches Europe’s First & Only Licensed Severe Malaria Treatment
  • AMIVAS IRELAND LTD. RECEIVES MHRA AUTHORISATION FOR UK

Recent Comments

  1. A WordPress Commenter on AMIVAS IRELAND LTD. RECEIVES MHRA AUTHORISATION FOR UK

Artesunate for Injection® – USA        Artesunate Amivas® – EU

AMIVAS Inc.
  • Follow

ABOUT US

We are a pharmaceutical company delivering life-saving medicines to the world. We develop, commercialize and distribute Artesunate for severe malaria.

PRODUCT INFORMATION

Order Artesunate

Medical affairs

Product information

Report adverse drug reaction / adverse event

Severe malaria information

COMPANY

Home

Careers

Partnering

News

Contact

© Copyright 2026 AMIVAS. All Rights Reserved. Web Design by DIGITALO.